LIVE SESSION BRIEF Drug Manufacturers - General $255B Cap Quant: HOLD

Novartis AG (NVS) — Live Session & Technical Brief

Updated Nov 16, 2026 1:05 PM ET · Prev Close $160.50

Pro Workspace
Last Session Price
$161.59 +0.68%
+$1.09 vs $160.50 prior close
Intraday Range
$161.47 – $163.28
Open $162.36
Relative Volume
0.41x Avg
863,772 sh
52-Week Range
$123.24 – $170.46
Benchmark Alpha
+2.52% vs SPY
+3.23% vs QQQ
20-Session Trend +5.2%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (+0.68%) in Drug Manufacturers - General

Novartis AG (Nvs) is trading within a tight intraday band at $161.59 (+0.68%, 0.41x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, NVS is outperforming the S&P 500 by +2.52%. 14-day RSI stands at 60.8, keeping momentum in a bullish regime.

NEWS 70% Weight
Novartis' Cosentyx Gets Positive CHMP Opinion for Adolescents With HS

NVS' Cosentyx gains a positive CHMP recommendation for adolescents with moderate to severe HS, potentially expanding treatment options in Europe.

TECHNICAL 68% Weight
Moving Average Structure: Bullish Alignment

Price ($161.59) holds above both 20-day ($159.19) and 50-day ($149.17) moving averages.

Volume Confirmation
LOW VOLUME (0.41x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

NVS outperforming the S&P 500 by +2.52%
NVS Session
+0.68%
$161.59
S&P 500 (SPY)
-1.84%
$740.48
Nasdaq 100 (QQQ)
-2.55%
$662.59
Healthcare (XLV)
-0.09%
$188.68
Alpha vs SPY: +2.52% Alpha vs QQQ: +3.23% Alpha vs XLV: +0.77%

Recent NVS Catalyst Headlines

Verified Wire
What Siam Cement Holders Bought Into

If you only glanced at Siam Cement during a year of mixed earnings headlines and heated debates about environmental costs, the outcome may surprise you. Holding Siam Cement over the past year would have returned 33.3 , i

Yahoo Finance · Nov 16, 2026

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$157.20
Short-term support band
Upper Bound
$165.98
Short-term resistance band
Key Inflection Level
$159.19 (20-day SMA support)

Monitor volume expansion above 1.5x RVOL around $159.19 (20-day SMA support) for directional breakout confirmation.

Technical Regime (NVS)

BULLISH MA TREND
RSI (14)
60.8
Bullish
20-Day SMA
$159.19
Above 20d
50-Day SMA
$149.17
Above 50d
MACD Signal
Bearish
MACD 3.29
ADX (14)
25.7
Strong trend
10d Momentum
+0.41
Positive 10-day momentum

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Reddit communities: 2 comments (Neutral)

About Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Sector
Healthcare
Market Cap
$255B
Forward P/E
15.5x
Employees
75,883

Get Instant NVS Catalyst Alerts

Receive an email alert when NVS triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

NVS Session & Catalyst FAQ

Why is NVS stock trading near flat today?

Novartis AG (Nvs) is trading within a tight intraday band at $161.59 (+0.68%, 0.41x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, NVS is outperforming the S&P 500 by +2.52%. 14-day RSI stands at 60.8, keeping momentum in a bullish regime.

Is NVS stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.41x relative volume (low participation). Our multi-factor model currently rates NVS as HOLD. Review full valuation, quality, and timing signals on the NVS Buy or Sell Decision Brief →

What is NVS's intrinsic value and expected trading range?

At $161.59, NVS's modeled 1-to-3 session range is $157.20 – $165.98, with a key inflection level at $159.19 (20-day SMA support). Compare current price against multi-year cash flow projections in the NVS Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for NVS?

RSI at 60.8 reflects constructive bullish momentum. NVS trades at $161.59 relative to its 20-day SMA ($159.19) and 50-day SMA ($149.17), reflecting a bullish moving-average structure.

Tradestie Flagship Research & Market Hubs